The primary aim was to determine the action of pathophysiologically relevant adenosine concentrations (0.1-1 p M ) on adhesion of neutrophils to coronary endothelium. Further aims were to evaluate the nature and localisation of the adenosine receptor involved. and to assess the effect of endogenous adenosine. Methods: Adhesion was studied in isolated perfused guinea pig hearts by determining the number of cells emerging in the coronary effluent after intracoronary bolus injections of 600 000 neutrophils prepared from guinea pig or human blood. The system was characterised by the use of the proadhesive stimulus thrombin. Results: A 5 rnin infusion of adenosine (0.1-0.3 p M ) or the A, receptor agonist Nh-cyclopentyladenosine (CPA, 0.01 p M ) significantly increased adhesion from about 2 0 8 (control) to 30%. This effect was prevented by the A, receptor antagonist dipropyl-8-cyclopentylxanthine (DPCPX. 0.1 pM). It was not diminished by cessation of adenosine infusion 90 s prior to neutrophil injection. At a higher concentration of adenosine (1 pM), adhesion did not seem to be enhanced. However, coinfusion of the A2 receptor antagonist 3,7-dimethyl-1 -propargylxanthine (DMPX. 0.1 pM) with 1 IJ.M adenosine unmasked the A , action, adhesion rising to 39%. Adenosine had a quantitatively identical effect on adhesion of human neutrophils. Total ischaemia of 15 min duration raised adhesion of subsequently applied neutrophils to 35%. This effect was completely blocked by DPCPX, as well as by ischaeniic preconditioning (3 X 3 min). Preconditioning raised initial postischaemic coronary effluent adenosine from about 0.8 IJ.M to 1 .5 pM. Conclusions: The findings suggest a bimodal participation of adenosine i n the development of postischaemic dysfunction by an endothelium dependent modulation of neutrophil adhesion. Stimulation occurs via endothelial A, receptors at submicromolar adenosine levels, whereas cardioprotection by adenosine may in part relate to the use of pharmacologically high concentrations of adenosine or enhanced endogenous production after preconditioning. Moreover. in a recent study by our group. adenosine (0.1 to 0.2 pM) was found to be essential for inducing reperfusion damage by neutrophils in an isolated working heart preparation. ' In an attempt to resolve this discrepancy. the role of adenosine in neutrophil adhesion to intact coronary endothelium was examined at concentrations of 0.1 to 1 p,M. Since a strong influence of shear stress on adhesive cellcell interactions has become evident.' ' the approach chosen was to apply suspensions of guinea pig and human neutrophils to the complete coronary bed of isolated guinea pig hearts. perfused at physiological flow rates. This model also circunwents possible artefacts arising from alterations of endothelial cells during culture.' Another advantage concerns elaborating the site of action of adenosine. To date, only the effects of adenosine on neutrophils have been investigated: neglecting the possibility of endothelium mediated responses. This is deemed to be of interest, because not only neutrophils' but also coronary endothelial cells possess both A, and A2 adenosine receptors.'* " Selective prestimulation of the coronary vascular endothelium can be readily achieved in the perfusion model, avoiding contact of the infused neutrophils with adenosine.
i n the development of postischaemic dysfunction by an endothelium dependent modulation of neutrophil adhesion. Stimulation occurs via endothelial A, receptors at submicromolar adenosine levels, whereas cardioprotection by adenosine may in part relate to the use of pharmacologically high concentrations of adenosine or enhanced endogenous production after preconditioning. Czrr~io~~ti.scirltii-Research 1994;28: 1366-I 372 dhesion of polymorphonuclear neutrophils to the vascular endothelium is a crucial event in inflam-A mation and reperfusion injury.' ' The nature of the mediators involved in the case of cardiac reperfusion remains uncertain. Adenosine. which is produced by i s reported to have anti-inflammatory and after ischaemia when applied at concentrations of more than 1 F M .~ ' However. the concentrations detected in coronary venous blood under circumstances such as coronary insufficiency or percutaneous transluminal coronary angioplasty (PTCA) range between 0.1 and 1 pM.' Moreover. in a recent study by our group. adenosine (0.1 to 0.2 pM) was found to be essential for inducing reperfusion damage by neutrophils in an isolated working heart preparation. ' In an attempt to resolve this discrepancy. the role of adenosine in neutrophil adhesion to intact coronary endothelium was examined at concentrations of 0.1 to 1 p,M. Since a strong influence of shear stress on adhesive cellcell interactions has become evident.' ' the approach chosen was to apply suspensions of guinea pig and human neutrophils to the complete coronary bed of isolated guinea pig hearts. perfused at physiological flow rates. This model also circunwents possible artefacts arising from alterations of endothelial cells during culture.' Another advantage concerns elaborating the site of action of adenosine. To date, only the effects of adenosine on neutrophils have been investigated: neglecting the possibility of endothelium mediated responses. This is deemed to be of interest, because not only neutrophils' but also coronary endothelial cells possess both A, and A2 adenosine receptors.'* " Selective prestimulation of the coronary vascular endothelium can be readily achieved in the perfusion model, avoiding contact of the infused neutrophils with adenosine.
The primary objectives of this study were: (1) to determine what effect adenosine has on neutrophil adhesion to coronary endothelium under shear stress conditions, with special consideration of the (patho)physiologically relevant concentrations of adenosine; (2) to characterise pharmacologically and to localise the adenosine receptor (A, v A2 receptors; endothelium 11 neutrophil) responsible for a specific action; and (3) to investigate the consequences of ischaemia and preconditioning on neutrophil adhesion, defining the possible role of adenosine in both phenomena. The direct comparison of responses of guinea pig and human neutrophils served to elaborate the potential of the outlined perfusion model for investigating species differences in adhesion phenomena. and adenosine came from Boehringer Mannheim. Percoll was purchased from Pharmacia. Hydroxy-ethyl starch (HES) was from Fresenius, and 18-'4C]adenosine from Amersham Buchler. All other chemicals, including the salts for the buffer solutions, were obtained from Merck.
Isolution of neutrophils
Human neutrophils were isolated from venous blood of healthy donors, guinea pig neutrophils from fresh arterial blood, drawn, in both cases, into polypropylene syringes containing 0.1 % EDTA (disodium ethylenediamine tetra-acetate) for anticoagulation. The blood was centrifuged for 15 min at 350 g and the platelet-rich plasma removed. The remaining cells were sedimented in 6% hydroxy-ethyl starch for 75 rnin and the supernatant was centrifuged at 350 g for 10 min. The pellet was resuspended in phosphate buffered saline (PBS) containing 0.1% EDTA and layered over Percoll (density 1.077 g.ml-' for human cells and 1.082 for guinea pig neutrophils). After centrifugation at 400 g for 25 min and washing, the residual erythrocytes were destroyed by hypotonic lysis with 5 ml distilled water at 4°C (1 and 2 min for human and guinea pig neutrophils, respectively). The neutrophils were washed in PBS, centrifuged, and finally resuspended in tris buffered Tyrode solution. Purity (~9 5 % ) and viability (>95%) of the cell preparation was routinely controlled by light microscopy (Pappenheim stain and Trypan blue exclusion test). The cell count was determined and adjusted to a number of 600000 neutrophilsm-' buffer. This cell suspension was drawn into a polypropylene syringe (10 ml) immediately before the experiment. To determine neutrophil numbers in Tyrode solution and in samples of venous effluent (see below), cells were immediately counted in triplicate with a Coulter counter ZM.
Though the cells obtained by this procedure cannot be regarded as completely unperturbed, they still presented uniformly excellent responses (chemiluminescence, aggre ation, and chemotaxis) to stimulation with a chemotactic peptide.
Heart preparation and perjiusion
Hearts of male guinea pigs (body weight 200-300 g, stunned by neck dislocation) were isolated and perfused as "Langendorff' preparations at 37°C with a modified Krebs-Henseleit bicarbonate buffer, equilibrated with 94.4% O2 and 5.6% C 0 2 [pH 7.4 (SEM 0.02)]. The experimental details have been reported prev~ously.~~ The veins entering the right atrium were ligated, ensuring that the perfusate emerging from the coronary sinus passed through the pulmonary artery. The latter was cannulated to enable the collection of the coronary effluent. The perfusion pressure was continuously registered with a pressure transducer.
Experimental protocol
Experiments conformed with the Guide for the care and use of laboratory animals published by the US National Institutes of Health revised 198.5) .
A flow chart of the standard protocol is shown in fig 1. After the preparation and an initial period of 5 min of constant pressure perfusion at 60 mm Hg, the hearts were perfused at constant flow (5 mlmin-I) for 30 min. In experiments with DPCPX and DMPX, the substances were present in the perfusate from the onset of perfusion. For the treatment of hearts with thrombin, adenosine, CPA, or iloprost, respective stock solutions in isotonic saline were infused after the 30 min into the aortic cannula at rates calculated to yield the desired end concentration in the coronary perfusate. These volumes never exceeded SO pl.min-'. After a further equilibration period of 5 min, a 1 ml bolus of the Tyrode solution containing the neutrophils was applied evenly over 1 min into the coronary system via the aortic cannula with an infusion pump, resulting in a flow of 6 rn1.min-l during the bolus. Thus about 100 000 neutrophils.ml-' perfusate, or 600 000 neutrophils in total were infused. Coronary effluent was collected during the bolus and for the following 40 s to quantify the number of neutrophils leaving the coronary system (neutrophil output). Pilot studies had shown that only a negligible number of cells (< 1%) ever emerged in the following 5 rnin of perfusion. However, we have no knowledge as to whether the remaining cells were irreversibly retained or just severely retarded in washout.
In each case, a test bolus of equal volume and duration ( I nil. I niin) was sampled without coronary passage immediately before the intracoronary bolus to determine the number of cells actually leaving the syringe (neutrophil input). The percentage of neutrophils remaining adherent to the endothelium was then calculated as:
To test the validity of our model, we assessed neutrophil adhesion in response to thrombin, a well characterised, rapidly acting (within 5 min) proadhesive agent.I4 We carried out these experiments with different neutrophil numbers (6 X lo5 to 7 X 10' neutrophils per bolus) to establish whether percentual adhesion was influenced by the cell density. As this was not the case (n = 9, data not shown), we used the relatively low cell count of 6 X 10s per neutrophil bolus throughout our study.
In one particular group of experiments, the adenosine infusion was stopped after 5 min and the adenosine was washed out for 1.5 min before the injection of neutrophils. Since the half time of adenosine washout was about 10 s (fig 2), this procedure avoided contact between infused cells and infused adenosine.
In a further experimental set, neutrophils were incubated with 1 )*M adenosine for 15 rnin prior to injection. The hearts to which these particular cells were applied received 0. I p. M adenosine starting 5 min before. The effective perfusate adenosine concentration during the neutrophil bolus therefore amounted to approximately 0.26 pM. Myocardial ischaemia (global) was induced by interrupting perfusion for 15 min (zero flow) after the initial 30 rnin equilibration period. The temperature of the hearts was kept constant at 37°C during ischaemia by suspendin them in warm Tyrode buffer. After 1 rnin of reperfusion adenosine measurement were taken in I min intervals during the first 5 min of reperfusion.
Ischaemic preconditioning of the hearts was performed by interrupting coronary perfusion three times for 3 min, each ischaeniia being followed by a reperfusion period of 5 min. After the third reperfusion phase, the heart were subjected to a final global ischaemia of 15 min duration. Again, the temperature of the hearts was kept constant throughout the experiment. Application of the neutrophil bolus and adenosine sampling were carried out as described above. The time course of the preconditioning experiments is evident from fig 5. (at 5 ml.min-F ), the neutrophil bolus was injected. Effluent samples for 
Results
To test the ability of our model to detect changes in adhesivity. we first assessed neutrophil adhesion under control conditions and in response to ;i 5 min application of thrombin (table I) . tinder control conditions, about 10% of the injected guinea pig neutrophils did not emerge from the perfused coronary system at the chosen rate of coronary flow. Thrombin caused a significant rise in adhesion of the homologous neutrophils of about SO% versus control. As shown in tig 3 and table 11. adenosine (0.1 p M ) . infused into tem for 5 inin prior to and maintained during sion. enhanced adhesion of guinea pig neutrophils to about the same extent as thrombin.
To characterise the adenosine receptor involved in this effect pharmacologically. we applied the A , receptor agonist CPA (0.01 pM). also for 5 min. and. in another series of experiments, adenosins (0.1 p M ) together with the A , receptor antagonist DPCPX. The data in fig 3 show that CP,4 is able t o simulate the adenosine effect. whereas DPCPX completel> blocks it. DPCPX had no effect on adhesion [21(SEhil ?)(It retention] in the absence of exogenous adenosine. Thus the proadhesive effect of adenosine must clearly be mediated via the A , receptor subtype.
Coronary effluent adenosine levels dropped to baseline within I min after cessation of arterial infusion (fig 2) . Washout experiments, i n which the neutrophils were injected 1.5 min after the end of a 5 min infusion of adenosine (0.1 pM). showed fully sustained increases in retention .Adenosine wiis infused into the coronary perfusatc for 5 min before and durins the neutrophil bolus. whereas DMPX was prewnt in the perfusate froni the onset of the heart preparation. In the last set of experiments. neutrophils were preincubated with I FM adenosine. and the hearts received onl! 0.1 pM adenosine. ' > < 0.01 pM effluent adenosine. .:p<o.o5 1' contro1.
( fig 3) . Previous studies have shown that the intact endothelium is an efficient barrier for 0.1 p M adenosine." I' Consequently, A , receptors on the endothelial cells, and not those on the neutrophils or cardiac myocytes and vascular smooth muscle. must play the decisive role.
Although thrombin is capable of inducing endothelial production of prostacyclin,l9 the prostaglandin I2 analogue iloprost did not alter neutrophil adhesion (table I). Since both iloprost and adenosine -via the A2 receptor'" -can enhance endothelial cell CAMP, this is further evidence favouring the involvement of A , adenosine receptors. The result obtained with iloprost also helps to rule out an indirect adenosine effect on adhesion by way of a dilatation induced reduction of intravascular shear stress or by an increase in coronary surface area. At the concentration applied (0.01 pM), iloprost reduced perfusion pressure to at least the same extent as adenosine (data not shown). This lowering of shear stress elicited no increase of neutrophil adhesion (table I). Furthermore. CPA enhanced adhesion without causing any drop in perfusion pressure Interestingly, the proadhesive effect of adenosine showed a bell shaped concentration dependence with a maximum in the range of 0.1-0.3 p,M (table 11). At 1 p M adenosine, adhesion was again reduced to the control level. However, if the A, receptor antagonist DMPX (0.1 pM) was co-infused with 1 p,M adenosine, adhesion was further stimulated, increasing to 39(3)% (table 11). DMPX alone did not influence neutrophil adhesion (results not shown). When neutrophils were incubated with 1 pM adenosine for 15 min prior to infusion into hearts that had received 0.1 p M adenosine according to the standard protocol, adhesion was not reduced in comparison to untreated neutrophils (table 11) . Therefore, the adhesion reducing A2 receptors have to be located on the endothelium.
Subjecting the isolated hearts to global normothermic ischaemia of 15 min duration augmented subsequent adhesion of neutrophils, an effect that could be fully blocked by the Al receptor antagonist DPCPX (fig 4) . Preconditioning the hearts with three short ischaemic periods of 3 min each had quantitatively the same protective effect as A, receptor blockade (fig 4) . In the experiments without preconditioning, postischaemic adenosine levels in the venous effluent were initially 0.8 p,M and, at the time of neutrophil injection, about 0.45 p,M ( fig 5) . After preconditioning, the adenosine values were notably higher, initially about 1.5 pM and still in the order of 0.6 pM during the bolus (fig 5) .
To test the hypothesis that repetitive stimulation of A, receptors by preconditioning might lead to short term tachyphylaxis and therefore to cessation of the proadhesive effect, adenosine (0.1 p,M) was continuously infused over 30 min. Since adhesion remained enhanced [30 (7) 
Discussion
Several papers have been published concerning beneficial effects of adenosine on inflammatory processes in general.' on the extent of reperfusion injury.' and especially on a participation. via A , receptors, in the phenomenon of ischaemic preconditioning." " On the other hand. we have previously shown that endogenous adenosine (0.1-0.2 p M ) contributes to postischaemic reperfusion injury mediated by neutrophils in an isolated guinea pig heart model. and that this too depends on adenosine A, receptors.' According to the results obtained in the present study. adenosine (0.1-0.3 p M ) induces adhesion of guinea pig as well us of human neutrophils to the intact coronary system of guinea pig hearts by acting o n endothelial A , receptors. This proadhesive effect provides a basis for a deleterious action of adenosine. although we do not know the ultimate fate of the cells. that is. whether they emigrate into the tissue or are protractedly washed o u t .
The tinding that adenosine can enhance neutrophil adhesion via A, receptors corresponds to some results of Cronstein and coworkers." However. there seem to be differences concerning the underlying mechanisms. First. Cronstein's group relates its findings to an effect of adenosine on the neutrophil, whereas we demonstrate an effect elicited on the endothelium. Second. Cronstein's studies pertain to effects occurring when neutrophils were stimulated by a chemotactic peptide. in contrast LO our investigation using relatively unperturbed neutrophils. Third. we examined neutrophil adhesion under physiological shear stress, and not in quiescent culture dishes. Although species differences could also be involved in causing divergent results, there may well be several distinct ways of modulating neutrophil attachment to endothelial cells with adenosine. This could occur either via the previously described A! and A? receptors on neutrophils." or via endothelial A, and A? receptors. guinea pig coronary endothelial cells being known to possess both types. I" ' I In our model. the proadhesive effect vanished at a high adenosine concentration ( 1 pM). However. I p M adenosine further enhanced adhesion if applied in the presence of the A2 antagonist DMPX (table 11) . Although DMPX is not absolutely selective for A2 receptors. a submaximal concentration (0.1 k M ) was applied, that is. one which significantly but not completely reduced coronary dilatation elicited by I k M adenosine via A: receptor mechanisms (drop in coronary perfusion pressure 14( 1 ) and 2 3 2 ) mm Hg, with and without DMPX. respectively ). At such a low concentration. receptor specificity of DMPX should be largely guaranteed. The suppression of adhesion by 1 p M adenosine thus reflects the onset of inhibitory A2 actions' '' and complies with the fact that A? receptors have a lower affinity for adenosine than A, receptors." At tirst we assumed the responsible A, mechanisms to be those familiar in the neutrophil but. again. the endothelium proved to be the principal site of action: experiments involving pre-exposure of the neutrophil to micromolar concentrations of adenosine. while the endothelium was only confronted with low levels (0.26 pM), showed retention of the pro-adhesive action. Thus endothelial A , and A? receptors exert mutually antagonistic effects on neutrophil adhesion. Although the adhesion of neutrophils can clearly be selectively regulated by adenosine A, and A' receptors, the receptor subtype specific mechanisms of the endothelium still remain to be characterised. Synergism with the respective A , and A2 receptor actions on the neutrophil s e e m possible. The concept of a concentration dependent bimodal action of adenosine is additionally supported by the finding that the proadhesive effect of 15 minutes of global ischaemia, caused via the A, receptor and associated with coronary effluent adenosine levels in the submicromolar range. was notably attenuated by preconditioning (fig 4) , an intervention which lead to even higher postischaemic adenosine concentrations (initially > 1 pM). Because the A:
receptor mediated inhibition of adhesion was evoked at the endothelium in our model, it should be these initial values which set the stage for responsiveness towards subsequently applied neutrophils. Pertinantly. enhancement of adenosine release from ischaemic hearts after preconditioning has already been described in a different model." An alternative explanation for the effect of preconditioning on adhesion, namely desensitisation of the A, receptor, seems unlikely during short term ischaemia and preconditioning, there being no evidence for tachyphylaxis of the A, response following sustained (30 min) exposure of the endothelium to moderately elevated adenosine (0.1 pM).
The discrepant results concerning the role of adenosine in adhesion and in reperfusion injury (see, for example, references 3.9, 18, and 19 as opposed to 7 and 9) most likely arise from the range of adenosine concentrations employed, and therefore the receptor subtype engaged. Though adenosine at high concentrations inhibits various functions of neutrophils (aggregation,'" radical production"), these responses remain unaffected in both guinea pig and human neutrophils at adenosine concentrations below 1 kM." Similarly, in studies reporting inhibition of adhesion of neutrophils by adenosine, either adenosine analogues of higher potency and lower metabolic turnover than the physiological agent were applied at extreme levels of 10 to 200 pM,' " or adenosine itself was used in concentrations > 9 pM.' In vivo, however, adenosine concentrations in arterial and coronary sinus blood under basal conditions have been found to be about 0.08 kM.'" In blood leaving hearts subjected to PTCA or pacing induced ischaemia, adenosine levels are in the order of 0.1 to 1 F M .~ ' In the context of concentration dependency, it is also interesting to note that, in our present study, the adenosine concentrations in the postischaemic venous effluent of individual hearts at the onset of reperfusion (0.6-2.0 pM) and the respective degree of neutrophil adhesion correlated negatively (adhesion= 35-0.0065 X (adenosine] , regression coefficient 0.5).
There is another reason why most in vitro studies which have examined adenosine effects on neutrophils to date reflect more a scenario of pharmacological intervention than of postischaemic reperfusion. This is because the neutrophils were consistently incubated with high concentrations of adenosine.' ' 27 After an ischaemic insult, however, the adenosine concentration is only locally elevated, not systemically, due to rapid elimination of adenosine from plasma by vascular endothelium and red blood cells. Therefore, the endothelial cells and the few resident neutrophils within an ischaemic vessel may be "incubated' with raised adenosine concentrations, but not the circulating neutrophils that reach the infarcted area only during reperfusion. The same objection pertains to in vivo models in which adenosine was systemically applied.'" Certain characteristics of the adhesion model described here bear mentioning. The basal adhesion of 20% seems rather high and may reflect a certain degree of prestimulation of both the endothelial cells and the neutrophils. However, lower values were obtainable if shear stress was raised by increasing the coronary How (unpublished results). Moreover. approximately similar values of basal adhesion" ." as well as rite of onset and extent of stimulation with thrombini4 have been obtained in studies with cultured endothelium. Furthermore, we have no knowledge, so far, concerning the ultimate fate of the retained or retarded cells: the counting procedure gives a relatively rapid resolution, but does not directly yield long term insights.
The nature of both the endothelial and neutrophil localised adhesion molecules involved in the A, receptor effect reported here remains to be clarified. Thrombin has been shown to cause rapid induction (within five minutes) of shear stress resistant adhesion to cultured endothelial cells via externalisation of endothelial P electi in.^^ However, we have previously shown that guinea pig P selectin does not interact with human ne~trophils.'~ The characteristics of the adhesion induced by adenosine (rapid, resistant to shear stress), indicate that in this case too a preformed adhesion molecule other than P selectin (perhaps a ligand for L electi in'^) might be externalised to the endothelial cell surface. As intracoronary adhesion of human and guinea pig neutrophils responded to adenosine in exactly the same way, a species difference regarding the respective adhesion partner on the granulocytes seems unlikely.
In the face of the present results, it is difficult to explain why preconditioning in some animal models depends on A, receptor activation." ** Of course, the proadhesive effect of adenosine may be unique to guinea pig coronary endothelium. However, the benefit of Al receptor stimulation in the pertinant studies was determined without allowing for possible systemic actions of the applied agonists or antagonists with respect to neutrophil adhesion. Thus simulation of cardiac preconditioning by intravenous application of A, receptor agonists'* could evolve from acute neutropenia resulting from systemically stimulated neutrophil adhesion.
Although it is not yet clear whether human coronary endothelial cells also possess A, receptors, it is, nevertheless, appealing to relate the present findings to reperfusion of the human heart. At submicromolar concentrations (presumably relevant in reperfused myocardial tissue in man), the A, effect described here would cause adhesion of neutrophils to increase, thereby setting the stage for further neutrophil mediated tissue damage. Therefore, adenosine perhaps should not be expected to act as a cardioprotective agent7 under all circumstances, and Al antagonists may well exert beneficial effects in the reperfused heart in vivo, as already shown in ~i t r o .~ Conversely, it may be speculated that the beneficial use of high adenosine concentrations or substances that enhance endogenous adenosine levels sufficiently is in part due to the antiadhesive effect of endothelial A2 receptor stimulation. In this case A2 receptor blocking drugs would be potentially deleterious. Finally, the protective effect of preconditioning may be partly caused by increasing adenosine levels into the cardioprotective range.25
